BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37499118)

  • 21. Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways.
    Wang L; Moreira EA; Kempf G; Miyake Y; Oliveira Esteves BI; Fahmi A; Schaefer JV; Dreier B; Yamauchi Y; Alves MP; Plückthun A; Matthias P
    Cell Rep; 2022 Apr; 39(4):110736. PubMed ID: 35476995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6.
    Porter NJ; Wagner FF; Christianson DW
    Biochemistry; 2018 Jul; 57(26):3916-3924. PubMed ID: 29775292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
    Porter NJ; Mahendran A; Breslow R; Christianson DW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
    Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
    J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.
    Yan J
    DNA Cell Biol; 2014 Sep; 33(9):567-80. PubMed ID: 24932665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a fluorescent probe with HDAC6 selective inhibition.
    Zhang Y; Yan J; Yao TP
    Eur J Med Chem; 2017 Dec; 141():596-602. PubMed ID: 29102179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors.
    Ashraf QF; Quilates EJ; Olaoye OO; de Araujo ED; Gunning PT
    Methods Mol Biol; 2023; 2589():481-492. PubMed ID: 36255644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
    Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
    Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
    Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curriculum vitae of HDAC6 in solid tumors.
    Zheng YC; Kang HQ; Wang B; Zhu YZ; Mamun MAA; Zhao LF; Nie HQ; Liu Y; Zhao LJ; Zhang XN; Gao MM; Jiang DD; Liu HM; Gao Y
    Int J Biol Macromol; 2023 Mar; 230():123219. PubMed ID: 36642357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
    Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
    Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
    New M; Olzscha H; Liu G; Khan O; Stimson L; McGouran J; Kerr D; Coutts A; Kessler B; Middleton M; La Thangue NB
    Cell Death Differ; 2013 Oct; 20(10):1306-16. PubMed ID: 23703321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).
    He X; Li Z; Zhuo XT; Hui Z; Xie T; Ye XY
    Recent Pat Anticancer Drug Discov; 2020; 15(1):32-48. PubMed ID: 32065106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin K
    Dawood M; Hegazy MF; Elbadawi M; Fleischer E; Klinger A; Bringmann G; Kuntner C; Shan L; Efferth T
    Biochem Pharmacol; 2020 Oct; 180():114176. PubMed ID: 32721508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of HDAC6 in Autophagy and NLRP3 Inflammasome.
    Chang P; Li H; Hu H; Li Y; Wang T
    Front Immunol; 2021; 12():763831. PubMed ID: 34777380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group.
    Linciano P; Pinzi L; Belluti S; Chianese U; Benedetti R; Moi D; Altucci L; Franchini S; Imbriano C; Sorbi C; Rastelli G
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2080-2086. PubMed ID: 34583596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
    Balmik AA; Sonawane SK; Chinnathambi S
    Cell Commun Signal; 2021 May; 19(1):49. PubMed ID: 33933071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).
    Shen S; Kozikowski AP
    Expert Opin Ther Pat; 2020 Feb; 30(2):121-136. PubMed ID: 31865813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.